Manufacturing, Gene Therapies

Lonza, Prevail Therapeutics Partner on Novel AAV9 Gene Therapy Programs

October 08, 2019

The collaboration focuses on baculovirus/Sf9 expression system for Prevail's pipeline of novel AAV9-based gene therapy programs neurodegenerative diseases.

Astellas Invests $13 Million into Innovation Facilities for Cell and Gene Therapy

October 02, 2019

The new incubators are set to be operational starting in 2021.

Astellas Invests $13 Million into Innovation Facilities for Cell and Gene Therapy

October 02, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The new incubators are set to be operational starting in 2021.

BIA Separations Launches AAV Process Development Service to Accelerate Gene Therapy Production

September 19, 2019

The new program, Cornerstone, integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of gene therapy medicinal products.

Pfizer Invests $500 Million into Its Gene Therapy Facility

August 21, 2019

Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.

Eurofins Genomics Acquires Blue Heron Biotech, Expands Gene Synthesis Capabilities

August 12, 2019

The acquisition expands Eurofins Genomics’ gene portfolio while bolstering Blue Heron’s production capabilities.

Abcam Acquires EdiGene’s Entire Live Cell Lines and Lysates Portfolio

July 17, 2019

Abcam has acquired the entire live cell line and lysates portfolio of gene-editing therapy developer, EdiGene.

Amicus Partners with Catalent on Lysosomal Disease Gene Therapy Programs

July 03, 2019

Metabolic-disease biotech Amicus Therapeutics announced a manufacturing agreement with Catalent’s Paragon Gene Therapy unit for gene therapy manufacturing.

Source of Nucleic-Acid Asymmetry May Advance Gene Therapy

July 01, 2019

Pharmaceutical Technology's In the Lab eNewsletter

Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.

Partnership Forms to Standardize Cell and Gene Therapy Supply Chain Solutions

June 19, 2019

Be The Match BioTherapies and TrakCel have announced a collaboration to provide integrated solutions for companies developing cell and gene therapies.